Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilan Goldenberg

Showing results (1-10 of 484) with videos related to

Pageof 49
Sort By:
Cardiology Journal|July 25, 2008
Inflammatory markers and the risk of recurrent coronary events: the importance of dynamic risk assessmentIlan Goldenberg
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 25, 2005
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategiesIlan Goldenberg, Shlomi Matetzky
International Journal of Cardiology|September 3, 2019
QRS change in heart failure: When is the right time for cardiac resynchronization therapy?Arwa Younis, Ilan Goldenberg
Annals of Internal Medicine|April 6, 2011
Age and effectiveness of prophylactic implantable cardioverter-defibrillatorsAlon Barsheshet, Ilan Goldenberg
European Heart Journal|March 18, 2021
Extending the MADIT-ICD benefit score to heterogenous heart failure populationsArwa Younis, Ilan Goldenberg
Journal of Cardiovascular Electrophysiology|May 13, 2024
RE: Clinical implication of detected tachyarrhythmias in patients with implantable cardioverter defibrillatorsAmole Ojo, Ilan Goldenberg
Heart Rhythm|June 5, 2013
Instability of ventricular repolarization in long QT syndrome: is the corrected QT interval sufficient for risk assessment?Ilan Goldenberg, Alon Barsheshet
European Heart Journal|August 12, 2023
Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromesAlon Barsheshet, Ilan Goldenberg
Journal of Cardiovascular Electrophysiology|February 22, 2020
Patient selection for wearable cardioverter defibrillator therapy after myocardial infarction: How can we incorporate compliance into decision-making?Arwa Younis, Ilan Goldenberg
Clinics in Geriatric Medicine|November 28, 2006
Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac diseaseIlan Goldenberg, Arthur J Moss
Pageof 49

Showing results (1-10 of 484) with videos related to

Sort By:
Pageof 49
Cardiology Journal|July 25, 2008
Inflammatory markers and the risk of recurrent coronary events: the importance of dynamic risk assessmentIlan Goldenberg
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 25, 2005
Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategiesIlan Goldenberg, Shlomi Matetzky
International Journal of Cardiology|September 3, 2019
QRS change in heart failure: When is the right time for cardiac resynchronization therapy?Arwa Younis, Ilan Goldenberg
Annals of Internal Medicine|April 6, 2011
Age and effectiveness of prophylactic implantable cardioverter-defibrillatorsAlon Barsheshet, Ilan Goldenberg
European Heart Journal|March 18, 2021
Extending the MADIT-ICD benefit score to heterogenous heart failure populationsArwa Younis, Ilan Goldenberg
Journal of Cardiovascular Electrophysiology|May 13, 2024
RE: Clinical implication of detected tachyarrhythmias in patients with implantable cardioverter defibrillatorsAmole Ojo, Ilan Goldenberg
Heart Rhythm|June 5, 2013
Instability of ventricular repolarization in long QT syndrome: is the corrected QT interval sufficient for risk assessment?Ilan Goldenberg, Alon Barsheshet
European Heart Journal|August 12, 2023
Advancing personalized medicine: the power of collaborative registries of patients with inherited cardiac arrhythmia syndromesAlon Barsheshet, Ilan Goldenberg
Journal of Cardiovascular Electrophysiology|February 22, 2020
Patient selection for wearable cardioverter defibrillator therapy after myocardial infarction: How can we incorporate compliance into decision-making?Arwa Younis, Ilan Goldenberg
Clinics in Geriatric Medicine|November 28, 2006
Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac diseaseIlan Goldenberg, Arthur J Moss
Pageof 49